Press Room
The Rosalind and Morris Goodman Cancer Institute (GCI), affiliated with McGill University’s Faculty of Medicine and Health Sciences, brings together world-leading scientists and clinicians in a vibrant, collaborative environment. Our scientists are tackling the most important problems in cancer research through innovative thinking and a multidisciplinary approach, supported by world-leading Innovation Platforms.
On this page, you will find press releases, media advisories, media coverage, and annual reports, among others, allowing you to follow the GCI's latest news. For all interview or information requests from media representatives, please contact communications.gci [at] mcgill.ca (Daniel Caron) Senior Communications Advisor.
Press releases
Media coverage
- Avancée québécoise dans la recherche sur le cancer du poumon
- Breast cancer survival rates have doubled in the past 15 years, say researchers (published in CTV News)
- Le taux de survie au cancer du sein aurait doublé depuis 15 ans au Canada (published in CBC/Radio-Canada)
- Cancer du sein, Le taux de survie aurait doublé depuis 15 ans (published in la Presse)
- Le business pharmaceutique dopé à l’ARN (published in Le Devoir)
Annual reports
Monthly newsletter
Discover our Research
1. Cancer initiation
Discovering the mechanisms that make normal cells cancerous
2. Progression and metastasis
Determining how some cancers leave their primary site and colonize distant organs
3. Drug response and resistance
Identifying mechanisms by which cancers resist therapies and biomarkers that can predict response or resistance to therapy
Discover our Cancer Expertise
The GCI is proud to be a leader in the field of the following cancers:
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Ovarian Cancer
- Brain Cancer
- Liver Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Skin Cancer
- Lymphoma
- Leukemia
- Myeloma
- Pediatric Cancer
- Gastric Cancer
- Biliary Cancer
- Kidney Cancer
- Obesity-Associated Cancer
- Cancer Immunotherapy